Best Orthopaedic Regenerative Medicine Start-Up - Europe
Renovos is focused on commercialising synthetic nanoclay gels as a drug delivery technology and for use in a variety of regenerative medicine applications, where patient’s own cells are stimulated to promote repair. Our first targets are within orthopaedics, where we are developing our proprietary technology to revolutionise bone healing in affected patients. Our nanoclay gels can be injected to the site of a fracture, deliver powerful biological agents that accelerate healing in a proven highly-specific and localised manner. We believe this will bring a step-change in orthopaedics, allowing us to treat fractures more safely, effectively, and at a lower cost.